查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1470849

体外毒理学测试市场：按技术、方法、应用、最终用户产业划分 - 2024-2030 年全球预测

In-Vitro Toxicology Testing Market by Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging), Method (Biochemical Assay, Cellular Assay, Ex-vivo), Application, End-User Industry - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

体外毒理学测试市场规模预计2023年为122.1亿美元，预计2024年将达到134.9亿美元，2030年将达到252.1亿美元，复合年增长率为10.90%。

体外毒性测试市场采用细胞培养和器官培养来评估化学物质、药品和食品等物质的毒性。这种创新方法用于製药、化妆品和食品行业，在准确性、再现性和速度方面具有显着的优势。由于测试方法的进步、对动物测试态度的增强以及对具有成本效益的安全措施的需求不断增长，该市场正在蓬勃发展。一个潜在的成长领域在于药物和治疗方法开发中使用体外模型，这些模型密切模仿人类生物化学并最大限度地减少临床试验失败的发生率。此外，基因组学和蛋白​​质组学的进步提供了巨大的成长机会。然而，这个市场面临着诸如解释测试资料的复杂性、体内条件再现的困难以及监管复杂性等挑战，所有这些都导致​​了高昂的营运成本。未来的业务成长取决于重点研究，以提高体外测试系统的预测准确性，同时降低成本。与监管机构就测试认可和核准进行合作计算生物学和基因组学的进步以及3D细胞培养和器官晶片系统的创新正在成为确保更广泛的消费者基础并扩大市场的动力，同时遵守消费者安全标准。

主要市场统计
基准年[2023] 122.1亿美元
预测年份 [2024] 134.9亿美元
预测年份 [2030] 252.1亿美元
复合年增长率（%） 10.90%

技术 体外毒理学测试 技术选择的优先顺序很大程度取决于特定的研究需求

细胞培养技术是体外毒性测试的基石。这些技术通常涉及在严格控制的条件下培养细胞，以研究毒性机制并预测潜在的毒性作用。这些技术通常用于现实测试模型和复杂的毒性分析。高通量技术透过自动化样品处理和资料分析来加速体外毒性测试。分子影像提供了一种在细胞和分子层面上可视化和监测生物过程的非侵入性方法，这对于了解物质的毒性非常重要。组学技术涵盖基因组学、蛋白质组学和代谢体学，探索有毒物质影响的基本生物学途径。

方法 细胞测定在毒性、药物动力学和动态研究中的重要性

体外毒性测试已经透过多种方法不断发展，这些方法在确定物质的毒性和开发更安全的药物化合物方面发挥着重要作用。对于体外毒性测试，生化测定是製药、生物技术和研究实验室的首选方法，因为它们详细说明了目标分子和小分子化合物之间的相互作用。此方法着重于早期识别潜在有毒物质，具有成本效益和时间效益。酶测定、受体结合测定和次级讯号化验等生化测定为了解这些相互作用的性质和潜在影响提供了必要的见解。细胞测定是体外毒性测试的重要组成部分，因为它们提供了细胞对化合物和治疗的反应的概述。它更准确地模仿人类生理学，因此在基于需求的偏好方面得分更高。这些测定可用于确定新化合物的毒性、药物动力学和动态。使用器官型或组织切片培养的体外方法是安全性评估的首选方法，尤其是器官特异性毒性测试。利用电脑模拟模型进行毒性评估的In Silico方法正迅速普及，因为它们是非侵入性的、具有成本效益的，并且允许快速测试。

应用：注意力集中在改进测试方法，同时提供满足行业特定要求的准确可靠的结果。

由于 3D 人体皮肤模型的创建和对动物测试的依赖减少，整个行业中皮肤相关产品和化学物质的使用不断增加，皮肤毒性变得越来越重要。内分泌干扰领域研究可能导致荷尔蒙失衡并影响健康和发育的物质。主要医疗保健供应商正在与环境机构合作，加强对潜在内分泌干扰物的筛检，并鼓励化学和生态学毒性控制产业。眼毒理学是对可能损害眼组织的物质进行研究，并提供准确且可重复的眼部毒性测试产品，以提高眼部专用产品的安全性。系统毒理学评估物质对各种身体系统的影响。此测试解决方案是一项用于评估器官毒性风险、降低药物製造成本和开发时间的新服务。总体而言，体外毒性测试为安全评估提供了巨大的潜力和巨大的成长机会。过去两年，我们在改进测试方法方面取得了重大进展，同时提供了满足行业特定要求的准确可靠的结果。

最终用途：试管内测试积极用于食品和製药领域，以确保安全标准。

试管内毒性测试可确保各个领域的安全，每个领域都有特定于行业的方法来满足其不同的需求。化学公司透过发布专门的化学分析体外测试平台，继续推进体外评估，以确认有害影响并保护人类健康和生态系统。消费品产业依靠毒性测试来确保客户安全，同时分析护肤和家用产品的过敏性和刺激性。食品製造商正在采用体外毒性测试，透过先进的体外病原体鑑定试剂套件来评估添加剂的安全性。製药科学中的体外测试对于药物发现非常重要，它透过利用体外可用的物质来促进对毒性和功效的理解。安全标准和客户信心的提高很大程度上归功于体外毒性测试，每项进步都反映了行业不断变化的需求。

区域洞察

美洲，特别是美国和加拿大，由于慢性病的流行对生物医学研究的高需求，在体外毒性测试领域处于领先地位。政府措施和市场领导的强大影响力进一步巩固了其地位。欧洲也制定了《化学品註册、评估、授权和限制 (REACH) 法案》等法律规章，刺激了对高效可靠测试方法（特别是危害识别和风险评估）的投资，并倾向于试管内测试。儘管仍处于起步阶段，但由于医疗保健领域投资增加以及迫切需要遵守全球健康和安全法规，中东和非洲也是潜力巨大的市场。中国、日本和印度等亚太国家不断变化的消费需求正在推动该地区体外测试的成长。例如，中国增加了对生物医学研究的资助，日本则受益于强大的医疗保健框架和显着的研究促进政策。全球倡议、专利活动和研究进展，例如欧盟的地平线 2020计划和中国国家自然科学基金，强调了体外毒性测试的重要作用。

FPNV定位矩阵

FPNV定位矩阵对于评估体外毒性测试市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对体外毒理学测试市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估及资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行综合评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.体外毒性测试市场规模及预测如何？

2.在体外毒理学测试市场的预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3. 体外毒性测试市场的技术趋势和法规结构是什么？

4.体外毒性测试市场主要厂商的市场占有率为何？

5. 进入体外毒性测试市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 新型农业化学品和食品添加剂的药物发现和商业化研究与开发工作
      • 体外毒性试验在医疗设备评估的应用
    • 抑制因素
      • 技术限制和无法准确再现某些生物现象
    • 机会
      • 体外毒性测试的进展以及计算生物学在毒性资料分析中的应用
      • 政府计划推广无残忍测试方法并开发新的毒性测试方法
    • 任务
      • 在当前模式下，药物核准可能会失败。
  • 市场区隔分析
    • 技术：体外毒性测试技术的选择很大程度上取决于特定的研究需求。
    • 方法：细胞测定在毒性、药物动力学和动态的体外毒性测试中变得越来越重要。
    • 应用：人们越来越关注改进测试方法，同时提供准确可靠的结果，同时满足特定产业的要求。
    • 最终用途：积极使用体外测试来确保食品和製药领域的安全标准
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章体外毒理学测试市场：依技术分类

  • 细胞培养技术
  • 高通量技术
  • 分子影像
  • 体学技术

第七章体外毒理学测试市场：依方法

  • 生化分析
  • 细胞测定
  • 体外
  • 模拟

第八章体外毒理学测试市场：依应用分类

  • 经皮毒性
  • 内分泌干扰
  • 眼毒性
  • 系统毒理学

第九章体外毒理学测试市场：按最终用户产业

  • 化学品
  • 化妆品/家居用品
  • 食物
  • 药品和生物製药

第十章 北美、南美洲体外毒性测试市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太体外毒理学测试市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东、非洲体外毒性测试市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • LGC 临床诊断公司收购 QC 产品製造商 Kova International
    • ERBC 集团透过收购 Oncofactory 扩大临床前专业知识
    • IIVS 和 Toxys 签署协议，提供 ToxTracker 用于体外遗传毒性评估
  • 战略分析和建议

第14章竞争组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-A339DAEFAF18

[182 Pages Report] The In-Vitro Toxicology Testing Market size was estimated at USD 12.21 billion in 2023 and expected to reach USD 13.49 billion in 2024, at a CAGR 10.90% to reach USD 25.21 billion by 2030.

The in-vitro toxicology testing market employs cell cultures and organ cultures for toxicity evaluation of substances such as chemicals, drugs, and food. This innovative approach, used in pharmaceuticals, cosmetics, and the food industry, offers significant precision, repeatability, and speed benefits. The market is thriving due to advancements in testing methods, a rising ethos against animal testing, and the increased need for cost-effective safety measures. Potential growth areas lie in using in-vitro models in drug and therapeutic development, which closely mimic human biochemistry and minimize the occurrence of unsuccessful clinical trials. Further, the progress in genomics and proteomics presents considerable growth opportunities. The market, however, faces challenges such as the complexity of test data interpretation, the difficulty of replicating in-vivo conditions, and regulatory intricacies, all of which contribute to high operational costs. Future business growth hinges on focused research to enhance the predictive accuracy of in-vitro test systems while lowering costs. Collaborations with regulatory agencies for test recognition and approval advances in computational biology and genomics and innovations in 3D cell culture and organ-on-a-chip systems collectively drive market expansion, ensuring a broad consumer base is achieved while upholding consumer safety standards.

KEY MARKET STATISTICS
Base Year [2023] USD 12.21 billion
Estimated Year [2024] USD 13.49 billion
Forecast Year [2030] USD 25.21 billion
CAGR (%) 10.90%

Technology: Preference for in-vitro toxicology testing technology selection largely depends by specific research needs

Cell culture technologies serve as the cornerstone of in-vitro toxicology testing. They often involve growing cells under carefully controlled conditions to investigate the mechanisms of toxicity and predict potential toxic effects. These technologies are typically employed for realistic test models and intricate toxicity analysis. High throughput technology expedites in-vitro toxicology testing by automating sample processing and data analysis. Molecular imaging offers a non-invasive method to visualize and monitor biological processes at the cellular and molecular level, critical for understanding substance toxicity. OMICS technology, which encapsulates genomics, proteomics, and metabolomics, among others, probes into the underlying biological pathways affected by toxic substances.

Method: Cellular assays gained importance in toxicity, pharmacokinetics and pharmacodynamics in vitro toxicology testing

In-vitro toxicology testing evolves through multiple methodologies, each playing a crucial role in determining the toxicity of substances and developing safer pharmaceutical compounds. In in-vitro toxicology testing, biochemical assays are the most favored methods by pharmaceutical, biotech, and research institutions since they involve detailed investigation of the interactions between a target and a small molecule. This technique predominantly focuses on identifying potential toxic substances early, making it cost and time-efficient. Biochemical assays such as enzymatic assays, receptor-binding assays, and second messenger assays provide necessary insights into the nature of these interactions and potential impacts. Cellular assays hold an imperative space in in-vitro toxicology testing by providing a panoramic view of the cell's response to a compound or a treatment. They score high on need-based preference as they mimic human physiology more accurately. These assays help determine new compounds' toxicity, pharmacokinetics, and pharmacodynamics. Ex-vivo methods, using organotypic or slice cultures of tissues, are favored for safety evaluations, especially for organ-specific toxicity testing. In Silico processes utilize computer-simulated models for toxicity evaluation, a burgeoning preference owing to their non-invasive, cost-effective, and speedy testing abilities.

Application: Rising focus on improving testing methods while delivering accurate, reliable results catering to industry-specific requirements

Dermal toxicity gained importance due to the growing use of skin-related products and chemicals across industries due to 3D human skin model creation and reducing the dependence on animal testing. The endocrine disruption domain studies substances that can cause hormonal imbalances, impacting health and development. Major healthcare vendors collaborate with environmental agencies to boost screening of potential endocrine disruptors, encouraging chemical and ecological toxicity control industries. Ocular toxicity involves studying substances that can harm eye tissue, as it provides accurate and reproducible ocular toxicity testing products, ensuring greater safety for eye-specific products. Systemic toxicology evaluates the impact of substances on various body systems. This testing solution is a novel service for assessing organ toxicity risks, reducing costs and development time in drug manufacturing. Overall, in-vitro toxicology testing offers significant safety evaluation potential with vast growth opportunities. The last two years saw remarkable advancements aimed at improving testing methods while delivering accurate, reliable results catering to industry-specific requirements.

End-Use: In vitro testing used vigorously in food and pharma sectors to ensure safety standards

In-vitro toxicology trials ensure safety across diverse sectors, with specific methods adopted for each industry to address their different needs. Chemical corporations continually advance in-vitro evaluations to ascertain hazardous effects and safeguard human health and the ecosystem by releasing a specialized in-vitro testing platform for chemical profiling. Consumer product industries take advantage of toxicology tests to guarantee customer safety while analyzing allergenicity and irritancy in skincare and household items. Food manufacturers employ in-vitro toxicology testing for the safety evaluation of their additives through advanced in-vitro testing kits for pathogen identification. Critical for drug discovery, in-vitro testing in pharmacy facilitates the understanding of toxicity and efficacy by utilizing its in-vitro offerings. Enhancement of safety standards and customer trust can be attributed significantly to in-vitro toxicology testing, with each advancement mirroring the evolving industry needs.

Regional Insights

The Americas, particularly the U.S., and Canada, spearheading the in vitro toxicology testing field due to high biomedical research demand from high chronic disease prevalence. Government initiatives and the robust presence of market leaders further bolster their position. Europe also leans towards in-vitro testing, with legislation including Registration, Evaluation, Authorisation, and Restriction of Chemicals (REACH) law spurring investment into efficient and reliable testing methods, especially for hazard identification and risk assessment. Despite being nascent, the Middle East and Africa also demonstrate a high potential market, encouraged by the increased healthcare sector investment and the pressing need to comply with global health and safety regulations. Dynamic consumer demands in the Asia Pacific, including countries such as China, Japan, and India, propel the growth of in-vitro testing in this region. For example, China's funding for biomedical research is increasing, Japan benefits from a sturdy healthcare framework and notable pro-research policies, and healthcare investors are courting India's burgeoning economy. Global initiatives, patenting activities, and research advancements, such as the EU's Horizon 2020 project and China's National Natural Science Foundation funding, underscore the indispensable role of in-vitro toxicology testing.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the In-Vitro Toxicology Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the In-Vitro Toxicology Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the In-Vitro Toxicology Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioIVT LLC, Charles River Laboratories International, Inc., Creative Bioarray, ERBC Group, Eurofins Scientific SE, Evotec SE, F. Hoffmann-La Roche AG, Gentronix Limited, HD Biosciences Co., Ltd., INDIGO Biosciences, Inc., Inotiv, Inc., InSphero AG, Intertek Group PLC, Laboratory Corporation of America Holdings, LAUS GmbH, LGC Limited, Merck KGaA, Microbac Laboratories Inc., Oroxcell SAS, Promega Corporation, Qiagen N.V., SGS SA, Thermo Fisher Scientific Inc., Toxys, Inc., Vimta Labs Ltd., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the In-Vitro Toxicology Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Cell Culture Technology
    • High Throughput Technology
    • Molecular Imaging
    • OMICS Technology
  • Method
    • Biochemical Assay
    • Cellular Assay
    • Ex-vivo
    • In Silico
  • Application
    • Dermal Toxicity
    • Endocrine Disruption
    • Occular Toxicity
    • Systemic Toxicology
  • End-User Industry
    • Chemicals
    • Cosmetic & Household Products
    • Food
    • Pharmaceuticals & Biopharmaceuticals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the In-Vitro Toxicology Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the In-Vitro Toxicology Testing Market?

3. What are the technology trends and regulatory frameworks in the In-Vitro Toxicology Testing Market?

4. What is the market share of the leading vendors in the In-Vitro Toxicology Testing Market?

5. Which modes and strategic moves are suitable for entering the In-Vitro Toxicology Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. R&D initiatives for drug discovery and launch of novel agrochemicals and food additives
      • 5.1.1.2. Utilization of in-vitro toxicology testing for evaluation of medical devices
    • 5.1.2. Restraints
      • 5.1.2.1. Technical limitations and inability to accurately replicate certain biological phenomena
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in in-vitro toxicology testing and adoption of computational biology for analyzing toxicology data
      • 5.1.3.2. Government programs to promote cruelty-free testing methods and develop novel toxicology assays
    • 5.1.4. Challenges
      • 5.1.4.1. Chances of drug approval failures with the current models.
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Preference for in-vitro toxicology testing technology selection largely depends by specific research needs
    • 5.2.2. Method: Cellular assays gained importance in toxicity, pharmacokinetics and pharmacodynamics in vitro toxicology testing
    • 5.2.3. Application: Rising focus on improving testing methods while delivering accurate, reliable results catering to industry-specific requirements
    • 5.2.4. End-Use: In vitro testing used vigorously in food and pharma sectors to ensure safety standards
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. In-Vitro Toxicology Testing Market, by Technology

  • 6.1. Introduction
  • 6.2. Cell Culture Technology
  • 6.3. High Throughput Technology
  • 6.4. Molecular Imaging
  • 6.5. OMICS Technology

7. In-Vitro Toxicology Testing Market, by Method

  • 7.1. Introduction
  • 7.2. Biochemical Assay
  • 7.3. Cellular Assay
  • 7.4. Ex-vivo
  • 7.5. In Silico

8. In-Vitro Toxicology Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Dermal Toxicity
  • 8.3. Endocrine Disruption
  • 8.4. Occular Toxicity
  • 8.5. Systemic Toxicology

9. In-Vitro Toxicology Testing Market, by End-User Industry

  • 9.1. Introduction
  • 9.2. Chemicals
  • 9.3. Cosmetic & Household Products
  • 9.4. Food
  • 9.5. Pharmaceuticals & Biopharmaceuticals

10. Americas In-Vitro Toxicology Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific In-Vitro Toxicology Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa In-Vitro Toxicology Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. LGC Clinical Diagnostics Acquires QC Product Maker Kova International
    • 13.3.2. ERBC Group Extends its Preclinical Expertise with the Acquisition of Oncofactory
    • 13.3.3. IIVS and Toxys Entered into an Agreement to Offer ToxTracker for In-Vitro Genetic Toxicity Evaluation
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. IN-VITRO TOXICOLOGY TESTING MARKET DYNAMICS
  • FIGURE 7. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. IN-VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. IN-VITRO TOXICOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IN-VITRO TOXICOLOGY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY BIOCHEMICAL ASSAY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY BIOCHEMICAL ASSAY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELLULAR ASSAY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELLULAR ASSAY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY EX-VIVO, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY EX-VIVO, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY IN SILICO, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY IN SILICO, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DERMAL TOXICITY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DERMAL TOXICITY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ENDOCRINE DISRUPTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ENDOCRINE DISRUPTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY OCCULAR TOXICITY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY OCCULAR TOXICITY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SYSTEMIC TOXICOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SYSTEMIC TOXICOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CHEMICALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CHEMICALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETIC & HOUSEHOLD PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETIC & HOUSEHOLD PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY FOOD, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY FOOD, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMACEUTICALS & BIOPHARMACEUTICALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMACEUTICALS & BIOPHARMACEUTICALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 73. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 74. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 81. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 82. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 85. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 89. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 90. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 91. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 92. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 96. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 110. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 112. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 116. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 117. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 118. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 119. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 120. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 121. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 124. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 125. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 126. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 127. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 128. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 129. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 132. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 133. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 134. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 135. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 136. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 137. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 140. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 141. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 142. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 143. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 144. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 145. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 148. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 149. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 152. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 153. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 156. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 158. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 160. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 164. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 165. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 166. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 167. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 168. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 169. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 172. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 174. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 176. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 178. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 180. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 181. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 182. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 183. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 184. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 185. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 188. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 189. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 190. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 191. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 192. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 193. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 196. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 197. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 198. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 199. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 200. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 201. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 204. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 215. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 216. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 217. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 218. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 219. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 222. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 223. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 224. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 225. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 226. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 227. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 230. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 231. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 232. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 233. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 234. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 235. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 238. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 239. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 240. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 241. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 242. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 243. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 246. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 247. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 248. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 249. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 250. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 251. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 254. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 255. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 256. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 257. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 258. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 259. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 262. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 263. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 264. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 265. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 266. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 267. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 270. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 272. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 274. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 278. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 279. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 280. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 281. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 282. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 283. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 286. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 287. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 288. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 289. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 290. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 291. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 292. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 293. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 294. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 295. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 296. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 297. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 298. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 299. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 300. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 301. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 302. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 303. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 304. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 305. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 306. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 307. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 310. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 311. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 312. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 313. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 314. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 315. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
  • TABLE 318. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 320. SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 321. SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 322. SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY